Page last updated: 2024-08-25

narciclasine and Breast Neoplasms

narciclasine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Darro, F; Dumont, P; Ingrassia, L; Kiss, R; Lefranc, F; Ribaucour, F; Roland, I; Rouzeau, S; Thomas, S1

Other Studies

1 other study(ies) available for narciclasine and Breast Neoplasms

ArticleYear
The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.
    Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:9

    Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carcinoma; Caspases; Cytochromes c; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; fas Receptor; Female; Fibroblasts; Humans; Male; Mitochondria; Narcissus; Neoplasm Proteins; Phenanthridines; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor

2007